New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 8, 2014
06:36 EDTREGNRegeneron reports Q1 EPS $2.26, consensus 94c
Reports Q1 revenue $626M, consensus $609.47M. Net product sales were $362M in Q1, compared to $319M in 1Q13. EYLEA net product sales in the United States were $359M in Q1, compared to $314M 1Q13. ARCALYST net product sales were $3M in Q1, compared to $5M in 1Q13.
News For REGN From The Last 14 Days
Check below for free stories on REGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 16, 2014
07:31 EDTREGNRegeneron's EYLEA Injection granted designation for treatment of retinopathy
Subscribe for More Information
September 8, 2014
07:15 EDTREGNIBC Life Sciences to hold a conference
10th Annual Cell Line Development & Engineering Conference to be held in Berkeley, California on September 8-10.
September 4, 2014
05:37 EDTREGNRegeneron submits application for Eylea injection in Japan for macular edema
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use